Reduction of heparin dose is not beneficial to platelet function
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (1) , 186-190
- https://doi.org/10.1016/s0003-4975(00)01389-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy?The Annals of Thoracic Surgery, 1997
- The effects of carmeda bioactive surface on human blood components during simulated extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Risk and benefit of low systemic heparinization during open heart operationsThe Annals of Thoracic Surgery, 1994
- Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: A clinical studyThe Annals of Thoracic Surgery, 1993
- Inhibition of platelet function by heparinThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Decreased Blood Loss After Cardiopulmonary Bypass using Heparin-Coated Circuit and 50% Reduction of Heparin DoseScandinavian Journal of Thoracic and Cardiovascular Surgery, 1992
- Heparin dosing and monitoring for cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1990
- The mechanism of heparin‐induced platelet aggregationEuropean Journal of Haematology, 1989
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- On the Mechanism of Platelet Aggregation Induced by Heparin, Protamine and PolybreneScandinavian Journal of Haematology, 1972